Noninvasive prediction of axillary lymph node status in breast cancer using promoter profiling of circulating cell-free DNA.
Zhi-Wei GuoQing LiuXu YangGeng-Xi CaiBo-Wei HanLi-Min HuangChun-Xi LiZhi-Kun LiangXiang-Ming ZhaiLi LinKun LiMin ZhangTian-Cai LiuRui-Lin PanYing-Song WuXue-Xi YangPublished in: Journal of translational medicine (2022)
These results indicate that promoter profiling can be used to distinguish ALN-positive patients from ALN-negative patients, which may be helpful to guide the choice of cancer treatment.